Improving human papilloma virus vaccination rates throughout military treatment facilities

Volume 36, Issue 11   Pages 1323-1520 (7 March 2018)

Improving human papilloma virus vaccination rates throughout military treatment facilities
Original research article
Pages 1361-1367
Rachel Dawson, Keith Lemmon, Nidhi J. Trivedi, Shana Hansen
The four objectives of this study were to (1) educate military healthcare providers on HPV disease and vaccine, (2) assess short term recall of information presented at educational sessions, (3) assess provider comfort level with the vaccine, and (4) assess improvement in HPV vaccination rates.
Standardized interactive educational sessions were conducted at military primary care clinics with pre- and post-educational quizzes administered before and immediately following the sessions. Provider attitudes were assessed using Likert scale questionnaires. Vaccination rates in children and young adolescents ages 11-18 at one of the participating regions that had a champion and started a Quality Improvement (QI) project were assessed at baseline, at 3-months and at 6-months post sessions.
200 providers were reached at 48 primary care clinics during May 2014 through October 2015 with 200 quizzes and Likert scale questionnaires returned. There was increase in knowledge following the educational sessions as revealed in the pre- and post- test scores [t(57)=-5.04, p< 0.001]. There was a significant overall increase in comfort in answering patients’ and parents’ questions about HPV vaccine [p= 0.003]. There was a significant increase in the number of vaccines given at all the clinics 3-months after the educational sessions at the region who had a champion dedicated to monitoring vaccine rates and ensuring implementation efforts [p=0.01] and started a QI project. This increase was not sustained at 6-months [p=0.324].
Improvement in provider short term knowledge recall and comfort level in answering parents’ questions was seen. We found that educational sessions can improve HPV vaccination rates in military clinics that have a vaccine champion for up to 3-months. Further research into the effects of having clinic vaccine champions is critical.